C. Beylot, N. Auffret, F. Poli, J. Claudel, M. Leccia et al., Dr eno, Propionibacterium acnes: an update on its role in the pathogenesis of acne, J. Eur. Acad. Dermatol. Venereol. JEADV, vol.28, issue.271, 2014.

M. T. Leccia, N. Auffret, F. Poli, J. Claudel, S. Corvec et al., Dr eno, Topical acne treatments in Europe and the issue of antimicrobial resistance, J. Eur. Acad. Dermatol. Venereol. JEADV, vol.29, 2015.

G. G. Aubin, M. E. Portillo, A. Trampuz, and S. Corvec, Propionibacterium acnes, an emerging pathogen: From acne to implant-infections, from phylotype to resistance, M??decine et Maladies Infectieuses, vol.44, issue.6, 2014.
DOI : 10.1016/j.medmal.2014.02.004

P. B. Emer, S. Corvec, S. Tariel, N. Asseray, D. Boutoille et al., Significance of Propionibacterium acnespositive samples in spinal instrumentation, Spine, vol.33, issue.971, 2008.

M. E. Portillo, S. Corvec, O. Borens, and A. Trampuz, : An Underestimated Pathogen in Implant-Associated Infections, BioMed Research International, vol.56, issue.4, 2013.
DOI : 10.1111/j.1469-0691.2010.03359.x

URL : http://doi.org/10.1155/2013/804391

S. Corvec, G. G. Aubin, R. Bayston, and W. Ashraf, Which is the best treatment for prosthetic joint infections due to Propionibacterium acnes: need for further biofilm in vitro and experimental foreign-body in vivo studies? Acta Orthop, 2016.

R. Bayston, B. Nuradeen, W. Ashraf, and B. J. Freeman, Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection, Journal of Antimicrobial Chemotherapy, vol.60, issue.6, 2007.
DOI : 10.1093/jac/dkm408

U. Furustrand-tafin, S. Corvec, B. Betrisey, W. Zimmerli, and A. Trampuz, Role of Rifampin against Propionibacterium acnes Biofilm In Vitro and in an Experimental Foreign-Body Infection Model, Antimicrobial Agents and Chemotherapy, vol.56, issue.4, pp.5552-5563, 2012.
DOI : 10.1128/AAC.05552-11

U. F. Tafin, A. Trampuz, and S. Corvec, In vitro emergence of rifampicin resistance in Propionibacterium acnes and molecular characterization of mutations in the rpoB gene, J. Antimicrob. Chemother, vol.68, issue.523, 2013.

U. Furustrand-tafin, G. G. Aubin, G. Eich, A. Trampuz, and S. Corvec, Occurrence and new mutations involved in rifampicin-resistant Propionibacterium acnes strains isolated from biofilm or device-related infections, Anaerobe, vol.34, issue.116, 2015.
DOI : 10.1016/j.anaerobe.2015.05.003

G. G. Aubin, P. Emer, S. Kambarev, N. B. Patel, O. Lemenand et al., Propionibacterium namnetense sp. nov., isolated from a human bone infection, International Journal of Systematic and Evolutionary Microbiology, vol.66, issue.9, 2016.
DOI : 10.1099/ijsem.0.001204

URL : http://ijs.microbiologyresearch.org/deliver/fulltext/ijsem/66/9/3393_ijsem001204.pdf?itemId=/content/journal/ijsem/10.1099/ijsem.0.001204&mimeType=pdf&isFastTrackArticle=

G. G. Aubin, S. Kambarev, P. Emer, P. A. Lawson, and S. Corvec, Draft genome sequence of highly rifampin-resistant Propionibacterium namnetense NTS 31307302T isolated from a patient with a bone infection, Genome Announc, vol.4, pp.819-835, 2016.

K. Nakase, H. Nakaminami, Y. Takenaka, N. Hayashi, M. Kawashima et al., Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan, Journal of Medical Microbiology, vol.63, issue.5, 2014.
DOI : 10.1099/jmm.0.067611-0

R. Gonz-alez, O. Welsh, J. Ocampo, R. M. Hinojosa-robles, L. Vera-cabrera et al., In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico, Int. J. Dermatol, vol.49, 2010.

K. Sardana, T. Gupta, B. Kumar, H. K. Gautam, and V. K. Garg, A cross-sectional pilot study of antibiotic resistance in Propionibacterium acnes strains in Indian acne patients using 16s-RNA polymerase chain reaction: A comparison among treatment modalities including antibiotics, benzoyl peroxide, and isotretinoin, Indian Journal of Dermatology, vol.61, issue.1, 2016.
DOI : 10.4103/0019-5154.174025

K. Nakase, Y. Sakuma, H. Nakaminami, and N. Noguchi, Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV, Anaerobe, vol.42, issue.166, 2016.
DOI : 10.1016/j.anaerobe.2016.10.012

V. Cattoir, A. Varca, G. Greub, G. Prod-'hom, P. Legrand et al., In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance, Journal of Antimicrobial Chemotherapy, vol.65, issue.12, 2010.
DOI : 10.1093/jac/dkq383

J. Ruiz, Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection, Journal of Antimicrobial Chemotherapy, vol.51, issue.5, 2003.
DOI : 10.1093/jac/dkg222

J. Ersu, G. G. Aubin, P. Mercier, P. Nicollet, P. Emer et al., Characterization of Staphylococcus caprae clinical isolates involved in human bone and joint infections, compared with goat mastitis isolates, J. Clin. Microbiol, vol.54, issue.106, pp.1696-1711, 2016.

H. Brüggemann, A. Henne, F. Hoster, H. Liesegang, A. Wiezer et al., The Complete Genome Sequence of Propionibacterium Acnes, a Commensal of Human Skin, Science, vol.305, issue.5684, 2004.
DOI : 10.1126/science.1100330

I. Laponogov, D. A. Veselkov, M. K. Sohi, X. Pan, A. Achari et al., Breakage-Reunion Domain of Streptococcus pneumoniae Topoisomerase IV: Crystal Structure of a Gram-Positive Quinolone Target, PLoS ONE, vol.157, issue.3, 2007.
DOI : 10.1371/journal.pone.0000301.s003

M. Biasini, S. Bienert, A. Waterhouse, K. Arnold, G. Studer et al., SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information, Nucleic Acids Research, vol.42, issue.W1, 2014.
DOI : 10.1093/nar/gku340

URL : https://academic.oup.com/nar/article-pdf/42/W1/W252/7438166/gku340.pdf

S. Onseedaeng and P. , Rapid Detection of genomic mutations in gyrA and parC genes of Escherichia coli by multiplex allele specific polymerase chain reaction, J. Clin. Lab. Anal, vol.30, issue.947, 2016.

C. Notredame, D. G. Higgins, and J. Heringa, A novel method for fast and accurate multiple sequence alignment, J. Mol. Biol, vol.302, issue.205, 2000.

P. Stothard, The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences, BioTechniques, vol.28, pp.1102-1104, 2000.

L. S. Redgrave, S. B. Sutton, M. A. Webber, and L. J. Piddock, Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success, Trends in Microbiology, vol.22, issue.8, 2014.
DOI : 10.1016/j.tim.2014.04.007

D. Ince and D. C. Hooper, Mechanisms and Frequency of Resistance to Premafloxacin in Staphylococcus aureus: Novel Mutations Suggest Novel Drug-Target Interactions, Antimicrobial Agents and Chemotherapy, vol.44, issue.12, pp.44-3344, 2000.
DOI : 10.1128/AAC.44.12.3344-3350.2000

L. B. Hovde, D. A. Simonson, and J. C. Rotschafer, Frequency of 1st- and 2nd-step topoisomerase mutations in Streptococcus pneumoniae following levofloxacin and moxifloxacin exposure, Diagnostic Microbiology and Infectious Disease, vol.60, issue.3, 2008.
DOI : 10.1016/j.diagmicrobio.2007.10.007

Z. Zhang, J. Lu, Y. Wang, Y. Pang, and Y. Zhao, Prevalence and Molecular Characterization of Fluoroquinolone-Resistant Mycobacterium tuberculosis Isolates in China, Antimicrobial Agents and Chemotherapy, vol.58, issue.1, 2014.
DOI : 10.1128/AAC.01228-13

T. Horii, Y. Suzuki, A. Monji, M. Morita, H. Muramatsu et al., Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs, Diagnostic Microbiology and Infectious Disease, vol.46, issue.2, pp.46-139, 2003.
DOI : 10.1016/S0732-8893(03)00037-3

M. Matsumoto, K. Shigemura, T. Shirakawa, Y. Nakano, H. Miyake et al., Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography, International Journal of Antimicrobial Agents, vol.40, issue.5
DOI : 10.1016/j.ijantimicag.2012.06.021

S. Page, F. Vernel-pauillac, O. O-'connor, S. Bremont, F. Charavay et al., Real-Time PCR Detection of gyrA and parC Mutations in Streptococcus pneumoniae, Antimicrobial Agents and Chemotherapy, vol.52, issue.11, pp.82-90, 2008.
DOI : 10.1128/AAC.00082-08

URL : https://hal.archives-ouvertes.fr/pasteur-00451015

D. Drudy, L. Kyne, R. O-'mahony, and S. , Fanning, gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027, Emerg. Infect. Dis, vol.13, issue.504, 2007.

J. M. Sierra, J. G. Cabeza, M. Ruiz-chaler, T. Montero, J. Hernandez et al., The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae, Clinical Microbiology and Infection, vol.11, issue.9, 2005.
DOI : 10.1111/j.1469-0691.2005.01211.x

Y. Kakinuma, Y. Maeda, C. Mason, C. E. Goldsmith, W. A. Coulter et al., Molecular characterisation of the quinolone resistance-determining regions (QRDR) including gyrA, gyrB, parC and parE genes in Streptococcus pneumoniae, Br. J. Biomed. Sci, pp.69-123, 2012.

C. Isnard, R. Lienhard, S. Reissier, S. Rodriguez, J. Kr?-ahenbühl et al., In vitro antimicrobial susceptibility of Alloscardovia omnicolens and molecular mechanisms of acquired resistance, Diagnostic Microbiology and Infectious Disease, vol.84, issue.3, 2016.
DOI : 10.1016/j.diagmicrobio.2015.08.009

Y. Fu, W. Zhang, H. Wang, S. Zhao, Y. Chen et al., Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli, BMC Infect. Dis, vol.13, issue.8, 2013.

M. Takigawa, Y. Tokura, S. Shimada, F. Furukawa, N. Noguchi et al., Acne Study Group, Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris, J. Dermatol, vol.40, issue.620, 2013.